Investigational Studies

Cardiol Therapeutics Inc. is a leader in producing 100% pure pharmaceutical CBD and developing groundbreaking therapies for heart disease. This Cardiol Therapeutics profile is part of a paid investor education campaign.* Overview Cardiol Therapeutics Inc. (TSX:CRDL;OTCQX:CRTPF) is a drug innovation company focused on creating the purest and safest CBD therapies in the market while innovating […]

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/home/news/drugs-in-the-pipeline/fda-accepts-bla-for-tissue-based-regenerative-tx-for-pediatric-congenital-athymia/

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/home/news/drugs-in-the-pipeline/stro-001-gets-orphan-drug-designation-for-mutiple-myeloma/

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/home/news/drugs-in-the-pipeline/bardoxolone-gets-orphan-drug-status-for-autosomal-dominant-polycystic-kidney-disease/

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/home/news/drugs-in-the-pipeline/bardoxolone-gets-orphan-drug-status-for-autosomal-dominant-polycystic-kidney-disease/

Medical use? Recreational Use? Federal vs. State? These are many of the common questions and concerns your average patient has with respect to cannabis today and the answer isn’t quite as clear as we would like it to be; however, there is a linguistic trend steering towards the term “medicated” to replace, the pejorative, “high” […]

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/slideshow/slides/new-drug-product-inbrija/

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/slideshow/slides/new-drug-product-inbrija/

Pharmaceutical companies are looking to synthetic CBD for cannabis-based pharma drugs. Synthetic CBD may help pharmaceutical companies develop and commercialize CBD-based drugs at a lowered cost and with minimized regulatory hassle. Cannabidiol (CBD), one of the many cannabinoids in the cannabis plant, is known to possess medicinal and therapeutic properties without giving patients the high […]

Pharmaceutical companies are looking to synthetic CBD for cannabis-based pharma drugs. Synthetic CBD may help pharmaceutical companies develop and commercialize CBD-based drugs at a lowered cost and with minimized regulatory hassle. Cannabidiol (CBD), one of the many cannabinoids in the cannabis plant, is known to possess medicinal and therapeutic properties without giving patients the high […]

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/home/news/drugs-in-the-pipeline/pamrevlumab-gets-orphan-drug-designation-for-duchenne-muscular-dystrophy/

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/home/news/drugs-in-the-pipeline/pamrevlumab-gets-orphan-drug-designation-for-duchenne-muscular-dystrophy/

American Financial Group Inc decreased its stake in Celgene Corp (CELG) by 40% based on its latest 2019Q1 regulatory filing with the SEC. American Financial Group Inc sold 40,000 shares as the company’s stock rose 5.82% with the market. The institutional investor held 60,000 shares of the major pharmaceuticals company at the end of 2019Q1, […]

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/home/news/drugs-in-the-pipeline/cbd-gel-gets-fast-tracked-for-behavioral-symptoms-associated-with-fragile-x-syndrome/